Single-Cell Metabolome

Learn how IsoPlexis’ multi-omics (metabolomics + functional proteomics) provides a critical and uniquely capable tool for addressing functional and metabolic changes that accompany adaptive resistance development.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

Metabolome characterizes signaling mechanisms driving resistance
Enabling researchers to better develop combination therapies
Combatting drug-resistant cell state and preventng drug resistance
A Deeper Look

More about this

Metabolome Characterizes Signaling Mechanisms Driving Resistance

IsoPlexis’ Single-Cell Metabolome solution was employed in the analysis of the resistance pathways of BRAFV600EM397 mutant melanoma cells treated with BRAF inhibitor (BRAFi).

Download this Product Sheet to learn more!

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Get the